BRKR
Bruker Corporation · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.5% · netto nieuwe posities -5.3% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 38.48K | $1.97M | n/a | n/a |
| Q2 2026 | 119 | +10 | 81.03M | $4.87B | +18 | −7 |
| Q1 2026 | 111 | -2 | 77.83M | $2.81B | +8 | −11 |
| Q4 2025 | 114 | +1 | 81.30M | $3.83B | +4 | −2 |
| Q3 2025 | 19 | 0 | 49.38M | $1.60B | +3 | −4 |
| Q2 2025 | 17 | +3 | 44.89M | $1.85B | +4 | −1 |
| Q1 2025 | 11 | 0 | 11.41M | $475.20M | +3 | −3 |
| Q4 2024 | 11 | -2 | 10.42M | $610.89M | +1 | −3 |
| Q3 2024 | 12 | -1 | 5.68M | $392.44M | n/a | −1 |
| Q2 2024 | 13 | n/a | 8.60M | $549.04M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.73M | +63.4% | $446.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 10.96M | -1.1% | $356.00M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | The Vanguard Group ✦ (passief) | 10.40M | -0.3% | $338.03M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (passief) | 3.74M | -1.2% | $121.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 2.19M | n/a | $71.01M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 6 | Geode Capital Management ✦ (passief) | 2.09M | +1.3% | $67.76M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 1.32M | -51.5% | $42.74M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Point72 Asset Management ✦ | 1.06M | Nieuw | $34.49M | 0.1% | New | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 847.36K | +65.6% | $27.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 624.96K | n/a | $20.30M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | JPMorgan Chase ✦ | 613.07K | n/a | $19.92M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 12 | Millennium Management ✦ | 570.27K | +470.4% | $18.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Glenview Capital ✦ | 319.67K | Nieuw | $10.39M | 0.3% | New | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 258.82K | -54.0% | $8.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 205.92K | Nieuw | $6.69M | 0.0% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 200.00K | -33.0% | $6.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 139.61K | -20.6% | $4.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 77.25K | +4.3% | $2.51M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 36.01K | -98.9% | $1.12M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $34.49M | 0.1% |
| Glenview Capital | $10.39M | 0.3% |
| D. E. Shaw & Co. | $6.69M | 0.0% |
Verlaten
| Norges Bank | $44.46M | was 0.0% |
| Scion Asset Management | $10.30M | was 18.3% |
| Arrowstreet Capital | $1.38M | was 0.0% |
| Marshall Wace | $251,814 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 339 houders, 136.43M aandelen, $4.78B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.00K aand · $105,740
Officer · 3.47K aand · $197,614
Officer · 2.00K aand · $115,200
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie